SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing strong bullish momentum as traders anticipate a potential surge toward the 80,000 level, fueled by optimism surrounding Treasury bond intervention and expectations of a broader crypto bull cycle. The community remains highly focused on short-squeeze dynamics and the potential for regulatory developments to sustain current price action.

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MSTR is trending as investors react to the company's newly created $1.59 billion USD cash pool and its ongoing Bitcoin treasury strategy, with the community actively debating whether the stock's recent dilution is hindering its price recovery compared to Bitcoin's rally. The sentiment remains polarized, with bullish retail traders expecting a short squeeze to follow Bitcoin's momentum, while skeptics point to NAV decay and share issuance as ongoing headwinds.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors weigh reported hardware price hikes and circular financing concerns against massive expectations for its upcoming earnings report. The community remains sharply divided, with some bulls viewing the price power as proof of relentless demand, while skeptics warn of potential market manipulation and unsustainable AI hype.

XPeng, Inc. engages in the design, development, manufacture, and marketing of smart electric vehicles. Its products are environmentally friendly vehicles, namely an SUV (the G3) and a four-door sports sedan (the P7). It also provides a range of services to the clients, including supercharging service, maintenance service, ride-hailing service and vehicle leasing service. The company was founded by Xiao Peng He, Heng Xia, and Tao He in 2015 and is headquartered in Guangzhou, China.

XPeng Inc - ADR

XPeng stock is trending following its recent report of strong delivery growth and the upcoming global launch of its MONA L03 model, with community sentiment divided between excitement over its robotics and AI-driven potential and frustration over ongoing downward price pressure. Investors are actively discussing the company's $900 million capital raise for its robotics subsidiary, viewing it as a strategic move to validate the brand's long-term technology roadmap while balancing its core automotive business.

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

BitMine Immersion Technologies is rallying as investors express optimism over the company's aggressive Ethereum treasury strategy and its proximity to a five-percent ownership target, though community discourse remains polarized regarding management's history of share dilution. Traders are closely monitoring the stock's sensitivity to broader crypto-market conditions and its potential for a squeeze as sentiment turns increasingly bullish.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is trending as investors monitor the upcoming 80th clinical event from the REGAL Phase 3 trial, driving significant short-covering and speculation regarding a potential buyout. The community is actively debating the trial's credibility, the therapeutic potential of its AML treatment, and its strategic value to major pharmaceutical companies.

Strive, Inc. engages in the provision of an asset management Bitcoin treasury. It is focused on maximizing value for shareholders, accumulating bitcoin and outperforming bitcoin over the long run. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani, and Kyle Fairbanks on March 9, 2022 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Strive Inc.

Strive Inc. is seeing increased investor interest as the community rallies around the stock's Bitcoin-heavy balance sheet and potential for a short squeeze amid positive momentum in the broader crypto market. Investors are closely monitoring the company's treasury management strategy and aggressive acquisition of Bitcoin as they anticipate a broader upward trend in digital assets.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors anticipate regulatory updates following the recent PDUFA date, with community focus centering on the company's BLA amendment and a potential pivot toward a refined indication for upper-limb function. While sentiment is divided, many bulls are encouraged by the potential for an extension and the reliance on 24-month HOPE-3 data to support a path to approval.

BTCT is a TRC20 token that is 100% backed by Bitcoin (BTC). The reserve addresses are published for anyone to audit.  Bitcoin uses peer-to-peer technology to operate with no central authority or banks; managing transactions and the issuing of bitcoins is carried out collectively by the network. Bitcoin is open-source; its design is public, nobody owns or controls Bitcoin and everyone can take part. Through many of its unique properties, Bitcoin allows exciting uses that could not be covered by any previous payment system.

Bitcoin TRC20

BTCT is seeing a surge in investor interest driven by broader positive momentum in Bitcoin, with the community actively speculating on the stock's potential for a short squeeze as it trades among the top daily gainers. Traders are highlighting the company's expansion into AI computing infrastructure and the successful development of its Georgia mining facility as key pillars supporting the current price action.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is facing a significant market selloff following an FDA clinical hold on its experimental RGX-121 gene therapy due to asymptomatic spinal MRI findings in study participants. While investors are debating whether the reaction is an overcorrection given the stock's other pipeline assets, the company has halted near-term resubmission efforts while awaiting further regulatory clarity.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BCSF +0.46% +1.07% DIVIDEND 1/26/26 = 20.73% APR

K.M.

LoganFive

StockTwits Web

Bain Capital Specialty Finance Inc

 +0.46% +1.07% DIVIDEND 1/26/26 = 20.73% APR